metabion
Private Company
Funding information not available
Overview
Metabion is a private, revenue-generating company and a global market leader in premium custom oligonucleotide synthesis services. It provides critical research tools and development services for the genetics, genomics, and synthetic biology sectors, with a growing focus on therapeutic oligonucleotides and GMP manufacturing. The company's strategy includes strategic collaborations, such as with baseclick GmbH, to offer integrated solutions for next-generation targeted therapeutics, positioning it as an enabler for drug developers rather than a traditional therapeutic developer itself.
Technology Platform
Expertise in high-purity custom oligonucleotide synthesis, modifications, and GMP manufacturing. Strategic collaboration with baseclick GmbH provides integrated click-chemistry conjugation for targeted therapeutic oligonucleotides.
Opportunities
Risk Factors
Competitive Landscape
Competes with large reagent suppliers (e.g., IDT, Thermo Fisher) for research oligos and with specialized CDMOs (e.g., Ajinomoto Bio-Pharma, CordenPharma) for therapeutic manufacturing. Its differentiation lies in premium quality, a focus on complex modifications, and the integrated click-chemistry service via the baseclick partnership.